These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Mitochondrial dysfunction and decrease in body weight of transgenic knock-in mouse model for TDP-43: the question of glucose? Jawaid A; Gapp K; Schulz PE J Biol Chem; 2014 Jun; 289(26):18593. PubMed ID: 24973427 [No Abstract] [Full Text] [Related]
43. STING-Induced Inflammation - A Novel Therapeutic Target in ALS? Van Damme P; Robberecht W N Engl J Med; 2021 Feb; 384(8):765-767. PubMed ID: 33626258 [No Abstract] [Full Text] [Related]
44. Reply to Jawaid et al.: mitochondrial dysfunction and decrease in body weight of transgenic knock-in mouse model for TDP-43: the question of glucose? Floss T J Biol Chem; 2014 Jun; 289(26):18594. PubMed ID: 25215360 [No Abstract] [Full Text] [Related]
45. Identification and prevention of heterotopias in mouse neocortical neural cell migration incurred by surgical damages during utero electroporation procedures. Wang B; Ji L; Bishayee K; Li C; Huh SO Anim Cells Syst (Seoul); 2020; 24(2):114-123. PubMed ID: 32489691 [No Abstract] [Full Text] [Related]
46. Brain Sample Preparation After Performing in Utero Electroporation to Proliferating and Differentiated Cells in the Developing Mouse Neocortex. Shin M; Kosodo Y Methods Mol Biol; 2024; 2794():187-200. PubMed ID: 38630230 [TBL] [Abstract][Full Text] [Related]
47. Untangling the structure of the TDP-43 N-terminal domain. Chang CK; Huang TH FEBS J; 2016 Apr; 283(7):1239-41. PubMed ID: 26848817 [No Abstract] [Full Text] [Related]
48. Correction to "RNA and Protein Interactors with TDP-43 in Human Spinal-Cord Lysates in Amyotrophic Lateral Sclerosis". Volkening K; Keller BA; Leystra-Lantz C; Strong MJ J Proteome Res; 2018 Jun; 17(6):2248. PubMed ID: 29737853 [No Abstract] [Full Text] [Related]
49. An Efficient System for Gene Perturbation in Embryonic Hippocampal Progenitors Using Ex Vivo Electroporation Followed by In Vitro Dissociated Cell Culture. Muralidharan B; D'Souza L; Tole S J Exp Neurosci; 2018; 12():1179069518767404. PubMed ID: 29760561 [TBL] [Abstract][Full Text] [Related]
50. A transportable, inexpensive electroporator for in utero electroporation. Bullmann T; Arendt T; Frey U; Hanashima C Dev Growth Differ; 2015 Jun; 57(5):369-377. PubMed ID: 25988525 [TBL] [Abstract][Full Text] [Related]
51. Chemically oligomerizable TDP-43: a novel chemogenetic tool for studying the pathophysiology of amyotrophic lateral sclerosis. Kanekura K; Yamanaka Y; Miyagi T; Kuroda M Neural Regen Res; 2022 Nov; 17(11):2434-2436. PubMed ID: 35535888 [No Abstract] [Full Text] [Related]
52. Jaw Clonus in an Autopsy Case of Amyotrophic Lateral Sclerosis with Multisystemic Involvement. Yamamoto T Mov Disord Clin Pract; 2014 Sep; 1(3):230-232. PubMed ID: 30713855 [No Abstract] [Full Text] [Related]
53. Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS. Su Z; Zhang Y; Gendron TF; Bauer PO; Chew J; Yang WY; Fostvedt E; Jansen-West K; Belzil VV; Desaro P; Johnston A; Overstreet K; Oh SY; Todd PK; Berry JD; Cudkowicz ME; Boeve BF; Dickson D; Floeter MK; Traynor BJ; Morelli C; Ratti A; Silani V; Rademakers R; Brown RH; Rothstein JD; Boylan KB; Petrucelli L; Disney MD Neuron; 2014 Sep; 83(5):1043-50. PubMed ID: 25132468 [TBL] [Abstract][Full Text] [Related]
54. TDP-43 loss of cellular function through aggregation requires additional structural determinants beyond its C-terminal Q/N prion-like domain. Budini M; Romano V; Quadri Z; Buratti E; Baralle FE Hum Mol Genet; 2015 Jan; 24(1):9-20. PubMed ID: 25122661 [TBL] [Abstract][Full Text] [Related]
55. Oligodendroglial response in the spinal cord in TDP-43 proteinopathy with motor neuron involvement. Rohan Z; Matej R; Rusina R; Kovacs GG Neurodegener Dis; 2014; 14(3):117-24. PubMed ID: 25115814 [TBL] [Abstract][Full Text] [Related]
56. Astrocytic TDP-43 pathology in Alexander disease. Walker AK; Daniels CM; Goldman JE; Trojanowski JQ; Lee VM; Messing A J Neurosci; 2014 May; 34(19):6448-58. PubMed ID: 24806671 [TBL] [Abstract][Full Text] [Related]
57. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones. Highley JR; Kirby J; Jansweijer JA; Webb PS; Hewamadduma CA; Heath PR; Higginbottom A; Raman R; Ferraiuolo L; Cooper-Knock J; McDermott CJ; Wharton SB; Shaw PJ; Ince PG Neuropathol Appl Neurobiol; 2014 Oct; 40(6):670-85. PubMed ID: 24750229 [TBL] [Abstract][Full Text] [Related]
58. The Role of Extracellular Matrix Components in the Spreading of Pathological Protein Aggregates. Moretto E; Stuart S; Surana S; Vargas JNS; Schiavo G Front Cell Neurosci; 2022; 16():844211. PubMed ID: 35573838 [TBL] [Abstract][Full Text] [Related]
59. The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD. Berning BA; Walker AK Front Neurosci; 2019; 13():335. PubMed ID: 31031584 [TBL] [Abstract][Full Text] [Related]
60. Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals. Tamaki Y; Shodai A; Morimura T; Hikiami R; Minamiyama S; Ayaki T; Tooyama I; Furukawa Y; Takahashi R; Urushitani M Sci Rep; 2018 Apr; 8(1):6030. PubMed ID: 29662239 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]